Literature DB >> 24421350

In vivo quantification of lymph viscosity and pressure in lymphatic vessels and draining lymph nodes of arthritic joints in mice.

Echoe M Bouta1, Ronald W Wood, Edward B Brown, Homaira Rahimi, Christopher T Ritchlin, Edward M Schwarz.   

Abstract

Rheumatoid arthritis (RA) is a chronic inflammatory joint disease with episodic flares. In TNF-Tg mice, a model of inflammatory-erosive arthritis, the popliteal lymph node (PLN) enlarges during the pre-arthritic 'expanding' phase, and then 'collapses' with adjacent knee flare associated with the loss of the intrinsic lymphatic pulse. As the mechanisms responsible are unknown, we developed in vivo methods to quantify lymph viscosity and pressure in mice with wild-type (WT), expanding and collapsed PLN. While no differences in viscosity were detected via multiphoton fluorescence recovery after photobleaching (MP-FRAP) of injected FITC-BSA, a 32.6% decrease in lymph speed was observed in vessels afferent to collapsed PLN (P < 0.05). Direct measurement of intra-lymph node pressure (LNP) demonstrated a decrease in expanding PLN versus WT pressure (3.41 ± 0.43 vs. 6.86 ± 0.56 cmH2O; P < 0.01), which dramatically increased to 9.92 ± 1.79 cmH2O in collapsed PLN. Lymphatic pumping pressure (LPP), measured indirectly by slowly releasing a pressurized cuff occluding indocyanine green (ICG), demonstrated an increase in vessels afferent to expanding PLN versus WT (18.76 ± 2.34 vs. 11.04 ± 1.47 cmH2O; P < 0.01), which dropped to 2.61 ± 0.72 cmH2O (P < 0.001) after PLN collapse. Herein, we document the first in vivo measurements of murine lymph viscosity and lymphatic pressure, and provide evidence to support the hypothesis that lymphangiogenesis and lymphatic transport are compensatory mechanisms to prevent synovitis via increased drainage of inflamed joints. Furthermore, the decrease in lymphatic flow and loss of LPP during PLN collapse are consistent with decreased drainage from the joint during arthritic flare, and validate these biomarkers of RA progression and possibly other chronic inflammatory conditions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24421350      PMCID: PMC3961082          DOI: 10.1113/jphysiol.2013.266700

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  46 in total

1.  The effect of transmural pressure on pumping activity in isolated bovine lymphatic vessels.

Authors:  N G McHale; I C Roddie
Journal:  J Physiol       Date:  1976-10       Impact factor: 5.182

2.  Experimental arthritis: Targeting joint lymphatic function.

Authors:  Jenny Buckland
Journal:  Nat Rev Rheumatol       Date:  2011-05-31       Impact factor: 20.543

3.  Expanded CD23(+)/CD21(hi) B cells in inflamed lymph nodes are associated with the onset of inflammatory-erosive arthritis in TNF-transgenic mice and are targets of anti-CD20 therapy.

Authors:  Jie Li; Igor Kuzin; Safiehkhatoon Moshkani; Steven T Proulx; Lianping Xing; Denise Skrombolas; Robert Dunn; Iñaki Sanz; Edward M Schwarz; Andrea Bottaro
Journal:  J Immunol       Date:  2010-04-30       Impact factor: 5.422

4.  Role of hyaluronic acid in joint lubrication.

Authors:  D A Swann; E L Radin; M Nazimiec; P A Weisser; N Curran; G Lewinnek
Journal:  Ann Rheum Dis       Date:  1974-07       Impact factor: 19.103

5.  Involvement of the NO-cGMP-K(ATP) channel pathway in the mesenteric lymphatic pump dysfunction observed in the guinea pig model of TNBS-induced ileitis.

Authors:  Ryan Mathias; Pierre-Yves von der Weid
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-12-28       Impact factor: 4.052

6.  Inhibition of lymphangiogenesis and lymphatic drainage via vascular endothelial growth factor receptor 3 blockade increases the severity of inflammation in a mouse model of chronic inflammatory arthritis.

Authors:  Ruolin Guo; Quan Zhou; Steven T Proulx; Ronald Wood; Rui-Cheng Ji; Christopher T Ritchlin; Bronislaw Pytowski; Zhenping Zhu; Yong-Jun Wang; Edward M Schwarz; Lianping Xing
Journal:  Arthritis Rheum       Date:  2009-09

7.  Noninvasive quantitative imaging of lymph function in mice.

Authors:  Sunkuk Kwon; Eva M Sevick-Muraca
Journal:  Lymphat Res Biol       Date:  2007       Impact factor: 2.589

8.  Longitudinal assessment of synovial, lymph node, and bone volumes in inflammatory arthritis in mice by in vivo magnetic resonance imaging and microfocal computed tomography.

Authors:  Steven T Proulx; Edmund Kwok; Zhigang You; M Owen Papuga; Christopher A Beck; David J Shealy; Christopher T Ritchlin; Hani A Awad; Brendan F Boyce; Lianping Xing; Edward M Schwarz
Journal:  Arthritis Rheum       Date:  2007-12

9.  Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.

Authors:  J Keffer; L Probert; H Cazlaris; S Georgopoulos; E Kaslaris; D Kioussis; G Kollias
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

10.  Power Doppler ultrasound phenotyping of expanding versus collapsed popliteal lymph nodes in murine inflammatory arthritis.

Authors:  Echoe M Bouta; Yawen Ju; Homaira Rahimi; Karen L de Mesy-Bentley; Ronald W Wood; Lianping Xing; Edward M Schwarz
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

View more
  36 in total

1.  Modeling Lymph Flow and Fluid Exchange with Blood Vessels in Lymph Nodes.

Authors:  Mohammad Jafarnejad; Matthew C Woodruff; David C Zawieja; Michael C Carroll; J E Moore
Journal:  Lymphat Res Biol       Date:  2015-12       Impact factor: 2.589

2.  Selective Sexual Dimorphisms in Musculoskeletal and Cardiopulmonary Pathologic Manifestations and Mortality Incidence in the Tumor Necrosis Factor-Transgenic Mouse Model of Rheumatoid Arthritis.

Authors:  Richard D Bell; Emily K Wu; Christopher A Rudmann; Megan Forney; Claire R W Kaiser; Ronald W Wood; Joe V Chakkalakal; Nicole D Paris; Alanna Klose; Guang-Qian Xiao; Javier Rangel-Moreno; Maria L Garcia-Hernandez; Christopher T Ritchlin; Edward M Schwarz; Homaira Rahimi
Journal:  Arthritis Rheumatol       Date:  2019-07-22       Impact factor: 10.995

Review 3.  Imaging the lymphatic system.

Authors:  Lance L Munn; Timothy P Padera
Journal:  Microvasc Res       Date:  2014-06-21       Impact factor: 3.514

4.  The relationship between lymphangion chain length and maximum pressure generation established through in vivo imaging and computational modeling.

Authors:  Mohammad S Razavi; Tyler S Nelson; Zhanna Nepiyushchikh; Rudolph L Gleason; J Brandon Dixon
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-08-04       Impact factor: 4.733

Review 5.  Lymphatic pumping: mechanics, mechanisms and malfunction.

Authors:  Joshua P Scallan; Scott D Zawieja; Jorge A Castorena-Gonzalez; Michael J Davis
Journal:  J Physiol       Date:  2016-08-02       Impact factor: 5.182

Review 6.  Experimental Models Used to Assess Lymphatic Contractile Function.

Authors:  Scott D Zawieja; Jorge A Castorena-Gonzalez; Brandon Dixon; Michael J Davis
Journal:  Lymphat Res Biol       Date:  2017-12       Impact factor: 2.589

Review 7.  Targeting lymphatic function as a novel therapeutic intervention for rheumatoid arthritis.

Authors:  Echoe M Bouta; Richard D Bell; Homaira Rahimi; Lianping Xing; Ronald W Wood; Clifton O Bingham; Christopher T Ritchlin; Edward M Schwarz
Journal:  Nat Rev Rheumatol       Date:  2018-01-11       Impact factor: 20.543

Review 8.  In Vivo Stability of Therapeutic Proteins.

Authors:  Joachim Schuster; Atanas Koulov; Hanns-Christian Mahler; Pascal Detampel; Joerg Huwyler; Satish Singh; Roman Mathaes
Journal:  Pharm Res       Date:  2020-01-03       Impact factor: 4.200

9.  Postprandial lymphatic pump function after a high-fat meal: a characterization of contractility, flow, and viscosity.

Authors:  Timothy Kassis; Sri Charan Yarlagadda; Alison B Kohan; Patrick Tso; Victor Breedveld; J Brandon Dixon
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-03-11       Impact factor: 4.052

Review 10.  Lymphatic system: an active pathway for immune protection.

Authors:  Shan Liao; P Y von der Weid
Journal:  Semin Cell Dev Biol       Date:  2014-12-19       Impact factor: 7.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.